MORSE Team
Toronto, September 7, 2022 – MORSE Consulting is delighted to announce the addition of 2 new team members, Jaclyn Beca and Sang Mi Lee who will enhance MORSE’s reimbursement expertise into pharmacoeconomics, generation and use of real world evidence (RWE) and development of innovative agreements. We are at an exciting time in drug discovery and research as new technologies, such as cell and gene therapies, offer opportunities to treat and…
Wishing you Season’s Greetings from MORSE Consulting! As we enter the holiday season and close our fifth year of operations, we would like to express our appreciation and gratitude to the pharmaceutical market access community, including our clients, strategic partners, and team members. We wish you all a safe, healthy, and enjoyable holiday break and the very best for 2022! Happy Holidays, —
Toronto, September 7, 2021 – MORSE Consulting is pleased to announce the addition of Katherine Scott as a Consultant. The Canadian public system remains one of the critical payers in this country’s pharmaceutical reimbursement pathway. This system is growing increasingly complex with new funding mechanisms for emerging gene and cell therapies, novel approaches related to outcomes-based agreements, evolving policies related to biosimilars, and variations in how provincial payers implement pCPA…
Happy Holidays from MORSE Consulting! As we enter the holiday season and the close of our fourth year of MORSE’s operations, we wish to share our gratitude to our community – our clients, strategic partners, and team members, for banding together and supporting each other through a challenging year. —
Toronto, September 9, 2020 – MORSE Consulting is pleased to announce that Sal Cimino has joined our team as Senior Consultant, Private Drug Plans. The private payer market is playing an increasingly important role in ensuring a product’s reimbursement success in Canada. With the introduction of new specialty biologics and gene therapies, private payers are turning to new cost containment strategies that strongly resemble the public payer market. Private payers…
Toronto, February 18, 2020 – MORSE Consulting is pleased to expand and strengthen our service offering with the addition of Anita Carrie and Roy Cairns. Affordability of effective and innovative medications within the current Canadian public funding model is becoming very challenging for the healthcare system. Increasing budgetary constraints coupled with complex treatments requiring consideration of different sources and levels of evidence are an issue for all stakeholders. To help…
Happy Holidays from MORSE Consulting! As we enter the holiday season and the close of MORSE’s third year of operation, we wish to express our heartfelt gratitude to the Pharmaceutical Market Access community. We wish you a safe, peaceful, and enjoyable holiday season and the very best for 2020! —
We wish you a safe, peaceful, and enjoyable holiday season and the very best for 2019. —
Toronto, October 9, 2018 –MORSE Consulting is pleased to announce the addition of Anita Gadhok as Senior Consultant. With more than 20 years of experience, Anita has worked with provincial drug programs, cancer agencies, private insurance, and community pharmacies in both Ontario and Manitoba. She has been involved in a number of ground-breaking initiatives including precursor work to support the development of the pan-Canadian Oncology Drug Review (pCODR), evaluation framework…
Toronto, February 7, 2018: Cornerstone Research Group and MORSE Consulting are pleased to announce the creation of a strategic partnership between our two organizations. This strategic partnership will simplify the logistical process for our clients utilizing our combined services when shepherding a product from reimbursement strategy, to CADTH submission and finally to pCPA negotiations. Together the collaboration between Cornerstone and MORSE offers clients a breadth of reimbursement consulting services…
As we enter the holiday season and the close of MORSE’s first year of operation, we wish to express our heartfelt gratitude to the pharmaceutical market access community. We are thankful to our clients, strategic partners (IMPACT, DKDA, and WestPAR), and our dedicated MORSE team members for helping to make this year a success. The 2017 year saw many significant changes in the Canadian reimbursement environment and it is likely…
Toronto, October 16, 2017 – Sherry O’Quinn and Arvind Mani are very pleased to announce that Lorraine Boyle has joined the MORSE team as a Senior Advisor. Lorraine is a former registered nurse with over 25 years of experience in the Canadian public health care system and pharmaceutical and biotechnology industry. Her experience spans sales, marketing, market access, government relations and patient advocacy. Therapeutic areas of experience and expertise include nephrology,…
Toronto, September 11, 2017 – Arvind Mani and Sherry O’Quinn are pleased to announce our newest strategic partner: Stephen Filbey of WestPAR – Western Policy Access & Reimbursement Consultancy. Stephen is the founder and Principal Executive Consultant of his Vancouver based company, WestPAR Consultancy Inc. He is an accomplished professional with 30+ years of experience in the pharmaceutical and related industries, 27 of which have been focused on issues throughout the…
Toronto, July 5, 2017 – Arvind Mani and Sherry O’Quinn are pleased to announce our newest strategic partnership with Dominika Dabrowski of DKDA Consulting. Dominika has 12+ years of consulting experience in the healthcare industry focused on global market access & reimbursement, and health economics and outcomes research (HEOR). She has extensive project and client management experience, having led numerous global projects, including payer research, advisory boards, literature reviews and reimbursement dossiers. Dominika specializes in payer…
Toronto, May 1, 2017 – Arvind Mani and Sherry O’Quinn are pleased to announce a strategic partnership with Brent Korte of Impact Consulting as well as to welcome a new MORSE team member, Avery Hughes as a Reimbursement Strategist. Brent Korte has more than 25 years of experience in pharmaceutical industry and consulting with both national and regional expertise in health policy government relations, market access, strategy development and implementation expertise…
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2022 MORSE Consulting Inc. All rights reserved. |
Site by Directica Media
MORSE Team - Info and details on - MORSE Consulting Inc.